Corrigendum | Published:

Organ-specific features of natural killer cells

Nature Reviews Immunology volume 11, page 880 (2011) | Download Citation

Nature Reviews Immunology 11, 658–671 (2011)

In the original version of this article, in the section under the subheading “CNS-specific NK cells in disease” on page 668, the humanized antibody daclizumab was incorrectly described as being specific for the IL-2 receptor β-chain (CD122). The corrected sentence now reads: “These findings might be relevant to the mode of action of daclizumab, a humanized antibody specific for the IL-2 receptor α-chain (CD25)”. The authors apologize for this error.

About this article

Publication history




  1. Search for Fu-Dong Shi in:

  2. Search for Hans-Gustaf Ljunggren in:

  3. Search for Antonio La Cava in:

  4. Search for Luc Van Kaer in: